Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Lymphodepletion Followed By Suicide-Gene-Transduced Donor Lymphocyte Infusion: A Strategy To Safely Enhance The Graft-Versus-Tumor Effect

Blood (2013) 122 (21): 153.

https://doi.org/10.1182/blood.V122.21.153.153

Published: 2013

Journal Articles

Sickle Cell Anemia and HSCT: Relation Between ATG, Chimerism, Gvhd and Outcome In Myeloablative Genoidentical Transplants For The SFGM-TC

Francoise Bernaudin, MD, Dominique Bories, MD, PHD, Jean-Hugues Dalle, MD, PHD, Marie Robin, MD, PhD, Regis Peffault de Latour, Benedicte Neven, Yves Bertrand, MD, Corinne Pondarre, MD, PHD, Jean-Pierre Vannier, Karima Yakouben, Mathieu Kuentz, Catherine Cordonnier, Nathalie Dhedin, MD, Isabelle Thuret, Patrick Lutz, Eliane Gluckman, MD, Gérard Socié, MD, PhD

Blood (2013) 122 (21): 971.

https://doi.org/10.1182/blood.V122.21.971.971

Published: 2013

Journal Articles

Prediction of Relapse and Impact of Immunomodulation Based On Quantitative RT-PCR of Insertion/Deletion Polymorphism for Chimerism Analysis in Acute Leukemia

Nathalie Jacque, MD, Stephanie Nguyen, MD, Jean Louis Golmard, Alice Garnier, MD, Madalina Uzunov, M.D., Veronique Leblond, Jean Paul Vernant, Dominique Bories, Nathalie Dhedin, MD

Blood (2012) 120 (21): 1966.

https://doi.org/10.1182/blood.V120.21.1966.1966

Published: 2012

Journal Articles

Clinical Phenotype and Response to Imatinib of Chronic Myelogenous Leukemia Patients Harbouring Atypical BCR-ABL Transcripts. A Retrospective Analysis From the French Group of CML (Fi-LMC) and the French Group of Molecular Biologists for Hematological Malignancies (GBMHM).

Benedicte Deau, MD, Mathias Montveneur, MStud, Valérie Coiteux, MD, Aline Renneville, MD, Francoise Rigal-Huguet, MD, Eric Delabesse, MD, PhD, Michel Tulliez, MD, Dominique Bories, MD, PhD, Aude Charbonnier, MD, PhD, Marie-Joelle Mozziconacci, MD, PhD, Thibault Legay, MD, Eric Lippert, PhD, Francois-Xavier Mahon, MD, PhD, Delphine Rea, MD, PhD, Jean-Michel Cayuela, PhD, Shanti Amé, MD, Marie-Pierre Gaub, MD, Martine Gardembas, MD, Odile Blanchet, MD, Bruno Audhuy, MD, Agnès Buzyn, MD, PhD, Elisabeth Mac Intyre, MD, PhD, Anna-Lisa Andreoli, MD, Oumedaly Reman, Nathalie Contentin, MD, Christian Bastard, MD, Jean-Christophe Ianotto, MD, Valérie Ugo, MD, PhD, Jean-Jacques Kiladjian, MD, PhD, Said Brahimi, MD, Viviane Dubruille, Jean-Francois Brantus, MD, Mohamad Sobh, Pharm., M., Stephane Morisset, Stat., Claude Preudhomme, MD, PhD, Sandrine Hayette, PhD, Franck E Nicolini, MD, PhD

Blood (2010) 116 (21): 3378.

https://doi.org/10.1182/blood.V116.21.3378.3378

Published: 2010

Journal Articles

Related Myeloablative Stem Cell Transplantation (SCT) to Cure Sickle Cell Anemia (SCA): Update of French Results

Blood (2010) 116 (21): 3518.

https://doi.org/10.1182/blood.V116.21.3518.3518

Published: 2010

Journal Articles

Quantitative Analysis of Chimerism Using Insertion/Deletion Polymorphisms Is An Useful Predictor of Relapse After Allogeneic Stem Cell Transplantation for Acute Leukemia.

Nathalie Jacque, Nathalie Dhédin, Jean Louis Golmard, Madalina Uzunov, Stéphanie Nguyen, Julien Lazarovici, Laurent Sutton, MD, Jean-Paul Vernant, Pr, Dominique Bories

Blood (2009) 114 (22): 3541.

https://doi.org/10.1182/blood.V114.22.3541.3541

Published: 2009

Journal Articles

Cartridge-Based Automated BCR-ABL mRNA Quantification: Towards Simplified Standardisation.

Jean-Michel Cayuela, PhD, PharmD, Elizabeth Macintyre, MD, PhD, Meryl Darlington, Raouf Ben Abdelali, MD, Xavier Fund, Patrick Villarèse, William Piterboth, Michel Tulliez, MD, Emmanuel Raffoux, MD, Francois Sigaux, MD, PhD, Delphine Rea, MD, PhD, Dominique Bories, MD, PhD, Valerie Seror

Blood (2009) 114 (22): 4261.

https://doi.org/10.1182/blood.V114.22.4261.4261

Published: 2009

Journal Articles

Clonal T Cell Large Granular Lymphocyte Leukaemia of Recipient Origin after Related Mismatched Allogeneic Haematopoietic Stem Cell Transplantation for Acute Myeloid Leukaemia as a Possible Consequence of Anti-Thymocyte Globulin in Conditioning Regimen

Loïc Fouillard, Christophe Marzac, Monique Lagrange, Stéphanie Huguet-Jacquot, Betina Fabiani, Frederic Davi, Christelle Mazurier, Elisabeth Soreau, jean-Philippe Laporte, Francoise Isnard, norbert-Claude Gorin, Dominique Bories

Blood (2008) 112 (11): 4312.

https://doi.org/10.1182/blood.V112.11.4312.4312

Published: 2008

Journal Articles

Incidence and Prognostic Impact of Gene Mutations in Older Patients with AML Treated in the ALFA-9801 Study.

Aline Renneville, Sylvie Castaigne, Sylvie Chevret, Laura Llopis, Nathalie Philippe, Olivier Nibourel, Sandrine Hayette, Jean-Michel Cayuela, Dina Naguib, Nathalie Gachard, Dominique Bories, Christian Bastard, Fatiha Merabet, Cécile Pautas, Christine Terré, Xavier Thomas, Hervé Dombret, Claude Preudhomme

Blood (2008) 112 (11): 1525.

https://doi.org/10.1182/blood.V112.11.1525.1525

Published: 2008

Journal Articles

Fully Functional NK Cells Promote Graft-to-Leukemia Effect, after Cord Blood Transplantation.

Vivien Beziat, Stéphanie Nguyen, Simona Lapusan, Baptiste Hervier, Nathalie Dhedin, Dominique Bories, Madalina Uzunov, Hélène Treberden-Negre, Françoise Norol, Zora Marjanovic, Jean-Pierre Marie, Jean-Paul Vernant, Patrice Debre, Bernard Rio, Vincent Vieillard

Blood (2008) 112 (11): 2319.

https://doi.org/10.1182/blood.V112.11.2319.2319

Published: 2008

Journal Articles

Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease

Blood (2007) 110 (7): 2749–2756.

https://doi.org/10.1182/blood-2007-03-079665

Published: 2007

Journal Articles

Clinical Outcome of 27 Imatinib Mesylate Resistant Chronic Myelogenous Leukemia (CML) Patients Harbouring a T315I BCR-ABL Mutation.

Franck E. Nicolini, MD, PhD, Emmanuel Bachy, MD, Sélim Corm, MD, Quoc-Hung Lê, MD, Sandrine Hayette, PhD, Dominique Bories, MD, PhD, Michel Tulliez, MD, Nathalie Sorel, MD, Francois Guilhot, MD, Laurence Legros, MD, François-Xavier Mahon, MD, PhD, Frédéric Maloisel, MD, Jean-Jacques Kiladjian, MD, PhD, Catherine Roche-Lestienne, PhD, Claude Preudhomme, MD, PhD, Mauricette Michallet, MD, PhD

Blood (2006) 108 (11): 2190.

https://doi.org/10.1182/blood.V108.11.2190.2190

Published: 2006

Journal Articles

Prospective Multicentric Molecular Study for Poor Prognosis Fusion Transcripts at Diagnosis in Adult ALL Patients - The LALA94 Experience.

Blood (2005) 106 (11): 4476.

https://doi.org/10.1182/blood.V106.11.4476.4476

Published: 2005

Journal Articles

P-Loop an T315I BCR-ABL Mutations in Chronic Myelogenous Leukemia (CML) Patients Are of Poor Prognosis, but the Y253H + E255K P-Loop Mutations Are of Even More Severe Prognosis in Chronic Phase. On the Behalf of the French Intergroup of CML (Fi-LMC Group).

Franck E. Nicolini, MD, PhD, Sélim Corm, MD, Quoc-Hung Lê, MD, Sandrine Hayette, PhD, Nathalie Sorel, PhD, Dominique Bories, MD, PhD, Stéphane Giraudier, MD, PhD, Michel Tulliez, MD, Philippe Rousselot, MD, Jean-Michel Cayuela, MD, François-Xavier Mahon, MD, PhD, Pascale Cony-Makhoul, MD, Jean-Jacques Kiladjian, MD, Olivier Tournilhac, MD, François Guilhot, MD, Catherine Roche-Lestienne, PhD, Claude Preudhomme, MD, PhD, Mauricette Michallet, MD, PhD

Blood (2005) 106 (11): 3284.

https://doi.org/10.1182/blood.V106.11.3284.3284

Published: 2005

Journal Articles

Imatinib Mesylate (IM), Is an Alternative to Donor Lymphocyte Infusion (DLI) for Chronic Myelogenous Leukemia (CML) in Relapse after Allogeneic Stem Cell Transplantation: A 3-Year Follow-Up Report, on the Behalf of the Société Française de Greffe de Moëlle et de Thérapie Cellulaire (SFGM-TC) and the France Intergroupe de la Leucémie Myéloïde Chronique (Fi-LMC).

Cecile Pautas, Frank Nicolini, PhD, Pascal Cony-Makhoul, Stephane Giraudier, Dominique Bories, Agnes Buzyn, Nathalie Dedhin, Mauricette Michallet, MD, François Guilhot, Jean-Pierre Jouet, Mathieu Kuentz

Blood (2004) 104 (11): 1017.

https://doi.org/10.1182/blood.V104.11.1017.1017

Published: 2004

Journal Articles

Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction

Mehdi Alizadeh, Marc Bernard, Bruno Danic, Charly Dauriac, Brigitte Birebent, Christine Lapart, Thierry Lamy, Pierre-Yves Le Prisé, Alain Beauplet, Dominique Bories, Gilbert Semana, Erwann Quelvennec

Blood (2002) 99 (12): 4618–4625.

https://doi.org/10.1182/blood.V99.12.4618

Published: 2002

NARROW

Lymphodepletion Followed By Suicide-Gene-Transduced Donor Lymphocyte Infusion: A Strategy To Safely Enhance The Graft-Versus-Tumor Effect

Sickle Cell Anemia and HSCT: Relation Between ATG, Chimerism, Gvhd and Outcome In Myeloablative Genoidentical Transplants For The SFGM-TC

Prediction of Relapse and Impact of Immunomodulation Based On Quantitative RT-PCR of Insertion/Deletion Polymorphism for Chimerism Analysis in Acute Leukemia

Clinical Phenotype and Response to Imatinib of Chronic Myelogenous Leukemia Patients Harbouring Atypical BCR-ABL Transcripts. A Retrospective Analysis From the French Group of CML (Fi-LMC) and the French Group of Molecular Biologists for Hematological Malignancies (GBMHM).

Related Myeloablative Stem Cell Transplantation (SCT) to Cure Sickle Cell Anemia (SCA): Update of French Results

Quantitative Analysis of Chimerism Using Insertion/Deletion Polymorphisms Is An Useful Predictor of Relapse After Allogeneic Stem Cell Transplantation for Acute Leukemia.

Cartridge-Based Automated BCR-ABL mRNA Quantification: Towards Simplified Standardisation.

Clonal T Cell Large Granular Lymphocyte Leukaemia of Recipient Origin after Related Mismatched Allogeneic Haematopoietic Stem Cell Transplantation for Acute Myeloid Leukaemia as a Possible Consequence of Anti-Thymocyte Globulin in Conditioning Regimen

Incidence and Prognostic Impact of Gene Mutations in Older Patients with AML Treated in the ALFA-9801 Study.

Fully Functional NK Cells Promote Graft-to-Leukemia Effect, after Cord Blood Transplantation.

Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease

Clinical Outcome of 27 Imatinib Mesylate Resistant Chronic Myelogenous Leukemia (CML) Patients Harbouring a T315I BCR-ABL Mutation.

Prospective Multicentric Molecular Study for Poor Prognosis Fusion Transcripts at Diagnosis in Adult ALL Patients - The LALA94 Experience.

P-Loop an T315I BCR-ABL Mutations in Chronic Myelogenous Leukemia (CML) Patients Are of Poor Prognosis, but the Y253H + E255K P-Loop Mutations Are of Even More Severe Prognosis in Chronic Phase. On the Behalf of the French Intergroup of CML (Fi-LMC Group).

Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only